نتایج جستجو برای: mpl mutation

تعداد نتایج: 292840  

Journal: :Blood 2017
Elisa Rumi Mario Cazzola

Philadelphia-negative classical myeloproliferative neoplasms (MPNs) include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). The 2016 revision of the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues includes new criteria for the diagnosis of these disorders. Somatic mutations in the 3 driver genes, that is, JAK2, CALR, and MPL, represe...

2016
Yonggoo Kim Joonhong Park Irene Jo Gun Dong Lee Jiyeon Kim Ahlm Kwon Hayoung Choi Woori Jang Hyojin Chae Kyungja Han Ki-Seong Eom Byung-Sik Cho Sung-Eun Lee Jinyoung Yang Seung-Hwan Shin Hyunjung Kim Yoon Ho Ko Haeil Park Jong Youl Jin Seungok Lee Dong Wook Jekarl Seung-Ah Yahng Myungshin Kim

Myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell disorders characterized by the proliferation of one or more myeloid lineages. The current study demonstrates that three driver mutations were detected in 82.6% of 407 MPNs with a mutation distribution of JAK2 in 275 (67.6%), CALR in 55 (13.5%) and MPL in 6 (1.5%). The mutations were mutually exclusive in principle except in ...

Journal: :Blood 2000
R Letestu N Vitrat A Massé J P Le Couedic V Lazar P Rameau F Wendling J Vuillier P Boutard E Plouvier M Plasse R Favier W Vainchenker N Debili

The thrombocytopenia and absent radii (TAR) syndrome is a rare disease associating bilateral radial agenesis and congenital thrombocytopenia. Here, we investigated in vitro megakaryocyte (MK) differentiation and expression of c-mpl in 6 patients. Using blood or marrow CD34(+) cells, the colony-forming unit (CFU)-MK number was markedly reduced. CD34(+) cells were also cultured in liquid medium i...

2007
Sulayma Al-Lamki Marie-Christine Morel-Kopp John Kwan Christopher Ward William Stevenson Ai Leen Ang Cheng Lim Hoon Seng Khoo Tan Hock Foong Lui Wai Keong Wong

Results Control subjects with a normal haematological profiles were all JAK2 V617F negative and expressed a variable amount of platelet Mpl protein (mean 80%±17, n=20). Patients with a myeloproliferative disease were variably positive for the mutation with JAK2 V617F detected in 73% of PV and 63% of ET patients. In these myeloproliferative patients, Mpl was reduced compared to the control group...

Journal: :Blood 2007
Luciana Teofili Fiorina Giona Maurizio Martini Tonia Cenci Francesco Guidi Lorenza Torti Giovanna Palumbo Angela Amendola Giuseppe Leone Robin Foà Luigi M Larocca

In the proposed revised World Health Organization (WHO) criteria for the diagnosis of BCR-ABL(-) myeloproliferative diseases (MPDs), exclusion criteria have been replaced by the presence of JAK2 mutations. We applied these criteria to 45 children with MPDs: 13 with polycythemia vera (PV) and 32 with essential thrombocythemia (ET). Among these 45 patients, 12 with ET and 5 with PV had a familial...

2002
Andrew W. Roberts Nicos A. Nicola Ruili Li

Mice with a null mutation in the thrombopoietin (TPO) receptor c-Mpl were generated by gene targeting. c-mpl-deficient mice developed normally but were deficient in megakaryocytes and severely thrombocytopenic. The hematocrit and numbers of mature circulating leukocytes were normal in mpT" mice, as was the distribution of morphologically identifiable precursors in hematopoietic tissues. Bone ma...

Journal: :Haematologica 2014
Bing Li Junqing Xu Jingya Wang Robert Peter Gale Zefeng Xu Yajuan Cui Lin Yang Ruixian Xing Xiaofei Ai Tiejun Qin Yue Zhang Peihong Zhang Zhijian Xiao

We tested 357 Chinese with primary myelofibrosis for mutations in CALR, JAK2 and MPL. CALR mutations were detected in 76 subjects (21%). There were 24 (32%) type-1 (L367fs*46) and 49 (64%) type-2 (K385fs*47) mutations. Seventy-two of 168 subjects (43%) without a JAK2 or MPL mutation had a CALR mutation. Subjects with a type-2 CALR mutation had lower hemoglobin concentrations (P=0.001), lower WB...

2014
Clemens Stockklausner Anne-Christine Klotter Nicole Dickemann Isabelle N. Kuhlee Christin M. Duffert Carolin Kerber Niels H. Gehring Andreas E. Kulozik

The interaction between thrombopoietin (THPO) and its receptor c-Mpl regulates downstream cytokine signaling and platelet homeostasis. Hereditary mutations of c-Mpl can either result in loss-of-function and thrombocytopenia or in gain-of-function and thrombocythemia and are important models to analyze the mechanism of c-Mpl activity. We have analyzed the effect of the c-Mpl P106L gain-of-functi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید